Please note: The information on this page is provided for informational purposes only. As of 2011, Simmons Hanly Conroy is no longer accepting cases involving Digitek and Digoxin.
Digitek (digoxin) was previously prescribed to treat heart failure and irregular heartbeat (arrhythmia). Some patients who took Digitek, Cardoxin, Lanoxin or Lanoxicaps suffered from overdose due to taking tablets that contained twice the active ingredient as approved.
Side effects and symptoms of Digitek/Digoxin overdose included:
- Decreased appetite
- Irregular heartbeats
Digitek & Digoxin Lawsuits
Following the realization that prescribed Digitek medications contained double the recommended amount of the active ingredient as approved, Digitek/Digoxin tablets were recalled. The dangerous levels of dosage of the active ingredient led to the recall of the drugs originally distributed by Mylan Pharmaceuticals and sold under the labels “Bertek” or “UDL.”
The medication was recalled nationwide in April 2008. Up until 2011, the pharmaceutical lawyers at Simmons Hanly Conroy worked diligently with patients experiencing health complications from the accidental overdose of its active ingredient. The firm has since resolved its Digitek and Digoxin lawsuits and is no longer accepting cases involving Digitek and Digoxin.
I am very pleased and had a wonderful experience with the firm. Would definitely use their services again.